The Bionow Precision Medicine Conference was in Leeds for 2026, hosted by Nexus at the University of Leeds with around 120 delegates, exhibitors and speakers coming together to explore advancements in personalised treatment approaches and their impact on patients.
The conference agenda included a state of the nation panel, followed by discussion topics covering precision oncology; detection and diagnosis; data and AI in precision medicine; a Patient Perspective presentation by the Sickle Cell Society; and advanced therapies, including cell and gene therapies. The event concluded with a tour of the Faculty of Biological Sciences suite of research facilities.
Read the full event summary here
Precision Medicine 2026 is supported by Nexus.
Agenda highlights:
Keynote Speakers
Jonathan O'Halloran, CEO, QuantuMDx
Elton Zeqiraj, Wellcome Trust Senior Fellow and Professor of Structural Biology, University of Leeds
State of the Precision Medicine Nation Panel
Chair: Gillian Dalgliesh, Associate Director, QIAGEN
Speakers
Elinor Fowler, Research Impact and Communications Officer, Heart Research UK
Anthony Lockett, Medical Director & Co-Founder, MEDQP
Tim Felton, Director, NIHR HealthTech Research Centre in Emergency and Acute Care
Jennifer Man, Director of Science, UK Biocentre
Precision Oncology
Speakers
Andrew MacDonald, Professor of Tumour Virology, University of Leeds
Donald Skifter, Senior VP Scientific Affairs, Discovery Life Sciences
Detection & Diagnosis
Speakers
Hood Thabit, Consultant Diabetologist, University of Manchester
Francesco Del Gado, Professor of Experimental Medicine & Consultant Rheumatologist, University of Leeds
Dan Carr, Senior Lecturer Pharmacology & Therapeutics, University of Liverpool
Data and AI in Precision Medicine
Chair: Ellen Hewitt, Head of Innovation and Business Development, University of Leeds
Speakers
Jonathan Peat, Global Business Development Manager, InvenireX
Mark Wappett, Head of BioInformatics, Almac Group
Dominic Mosses, CEO & Founder, Protostem-AI
Patient Perspective
John James, CEO, Sickle Cell Society
Advanced Therapies (including Cell & Gene Therapies)
Speakers
Cathy Hawley, Founder & CSO, Antigonie Biosciences
Mihaela Lorger, Professor of tumour immunology, University of Leeds
Leyuan Bao, Director of Research, Immunokey
- Reena Rathod, Associate Principal Development Scientist, RoslinCT
